Last reviewed: July 2, 2026
Last updated: July 2, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, the active ingredient in Wegovy, reduces appetite through GLP-1 receptor activation in the brain's appetite centers, helping people consume fewer calories without feeling deprived. Clinical trials show participants lose an average of 15% of body weight over 68 weeks. PlexusDx provides access to compounded semaglutide injections from licensed 503A pharmacies, making this medication affordable and convenient for all 50 states.
How Semaglutide Burns Fat Through Appetite Suppression
Semaglutide activates GLP-1 receptors in the hypothalamus, the brain region controlling hunger and fullness signals. When these receptors receive stimulation, your brain interprets satiety more quickly, causing you to eat smaller portions naturally. This mechanism doesn't create artificial energy expenditure; instead, it removes the biological drive that leads to overeating. Most users report feeling satisfied after eating far less food than before treatment began.
The fat-burning effect stems from a calorie deficit that feels sustainable rather than forced. When appetite-driven eating stops, people consistently consume 300–500 fewer calories daily without conscious restriction. Over weeks and months, this steady deficit mobilizes stored fat for energy. Research shows that semaglutide users maintain muscle mass better than those achieving weight loss through diet alone, meaning more of the lost weight comes from fat stores.
Metabolic Changes Beyond Reduced Calorie Intake
Semaglutide influences how your body processes glucose and manages insulin levels, creating secondary metabolic benefits beyond appetite control. GLP-1 receptors exist throughout the digestive system, pancreas, and liver, allowing semaglutide to slow gastric emptying and improve insulin secretion when blood sugar rises. These changes stabilize energy levels and reduce cravings for high-sugar foods that drive weight regain. People on semaglutide often report improved blood sugar control even before significant weight loss occurs.
The medication also may increase feelings of fullness by affecting nutrient absorption signals from the gut. Slower digestion means nutrients trigger satiety hormones over a longer period, extending the sensation of being satisfied. This is why many patients experience reduced interest in foods they previously couldn't resist. Combined with lower overall calorie consumption, these metabolic shifts create conditions where fat loss becomes the body's natural response.
Clinical Evidence for Semaglutide Weight Loss Results
The STEP trials, conducted across multiple continents with over 4,500 participants, demonstrated that semaglutide 2.4 mg weekly produces an average 15% reduction in body weight over 68 weeks compared to placebo's 2.6% reduction. Notably, 50% of semaglutide users achieved at least 15% weight loss, while 35% lost 20% or more of starting body weight. These results held true across different age groups, genders, and baseline weights, showing consistent effectiveness. Improvements in cardiometabolic risk factors—including blood pressure, cholesterol, and blood sugar—accompanied weight loss in trial participants.
Long-term data shows that weight loss plateaus around 6–12 months for most users, then stabilizes with continued medication use. Weight regain typically occurs after discontinuation, indicating that semaglutide works best as a sustained treatment rather than a short-term intervention. Real-world data from clinical practices mirrors trial outcomes, with most patients achieving 10–20% weight loss when taking the medication as prescribed.
PlexusDx Compounded Semaglutide: Access and Affordability
PlexusDx offers compounded semaglutide injections starting at $149 per month from licensed 503A compounding pharmacies, eliminating insurance barriers and membership fees. The medication is HSA/FSA eligible, providing tax-advantaged savings for qualifying accounts. All 50 states receive service, and no prior authorization delays treatment initiation. Your dose may need to go up as your body becomes accustomed to the medication, but your price won't—pricing remains flat across all dose levels.
Patients interested in personalized treatment optimization can add the Precision Peptide Genetic Test ($99 after the first month) to identify genetic predispositions affecting GLP-1 receptor sensitivity and fat metabolism pathways. This test analyzes key variants like GLP1R rs6923761 and FTO rs9939609, mapping 14 distinct pathways and 150+ genetic insights to guide dose timing and medication selection. PlexusDx uses this genetic information to match patients with semaglutide or complementary peptide therapies that align with their unique biological profile.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Does semaglutide actually burn fat, or does it just reduce hunger?
Semaglutide primarily works by reducing appetite through GLP-1 receptor activation, which leads to lower calorie consumption. This calorie deficit forces your body to mobilize fat stores for energy, resulting in fat loss. The medication doesn't artificially increase metabolic rate, but the sustained deficit it creates—typically 300–500 fewer calories daily—reliably converts to fat loss over time.
How much weight can I expect to lose with semaglutide?
STEP trial data shows average weight loss of 15% of body weight over 68 weeks, with 50% of users achieving at least 15% loss and 35% losing 20% or more. Individual results vary based on starting weight, adherence, diet quality, and exercise habits. PlexusDx's Precision Peptide Genetic Test can help predict your likelihood of optimal response based on GLP1R and other genetic markers.
How much does compounded semaglutide cost at PlexusDx?
PlexusDx compounded semaglutide injections start at $149 per month, with pricing remaining flat regardless of dose level. The medication is HSA/FSA eligible, and no insurance, membership fees, or prior authorization are required. Service is available across all 50 states.
Are there side effects to semaglutide, and are they permanent?
Common side effects include nausea, vomiting, diarrhea, and constipation, typically mild and most pronounced during dose escalation. Most side effects resolve within 2–3 weeks as the body adjusts. Serious side effects are rare at prescribed doses but may include pancreatitis or gallbladder issues; discuss personal risk factors with a healthcare provider. Side effects disappear after discontinuation.
How does PlexusDx's genetic test improve semaglutide results?
The Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes to assess your likely sensitivity to GLP-1 therapy and metabolic predispositions. Users with favorable GLP1R variants often achieve maximum response at lower doses, while those with less favorable variants may need higher doses or combination therapy. Testing guides personalized treatment optimization and helps PlexusDx providers select the best medication type for your genetic profile.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Can a Doctor Prescribe Wegovy for Weight Loss?
Why Are People Breaking Open Their Mounjaro Pens?